Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI)

CUSIP: 81726A209

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
30,025,160
Total 13F shares
667,184
Share change
-97,137
Total reported value
$2,341,958
Price per share
$3.51
Number of holders
14
Value change
-$330,207
Number of buys
5
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 81726A209?
CUSIP 81726A209 identifies SNTI - Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI) as of Q4 2024

As of 31 Dec 2024, Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 667,184 shares. The largest 10 holders included NEA Management Company, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, Virtu Financial LLC, STATE STREET CORP, BlackRock, Inc., Tower Research Capital LLC (TRC), and SBI Securities Co., Ltd.. This page lists 14 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.